AI-Assisted Medical Skincare System Offers Nearly 12 Million Personalized Formulations
New platform enables providers to approve tailored skincare blends using facial analysis and bioactive selection software.
New platform enables providers to approve tailored skincare blends using facial analysis and bioactive selection software.
The product is the first botulinum toxin type E approved for aesthetic use and is designed to deliver faster onset and shorter-lasting results than traditional neurotoxins.